| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |